The Bioabsorbables/Bioresorbables Center

Filter Your Results




BONITO Registry Compares Bioresorbable Scaffolds Versus Drug-Eluting Stents in CTOs

October 11, 2016 -- Findings from the BONITO registry comparing procedural and long-term outcomes for bioresorbable scaffolds (BRSs) versus drug-eluting stents (DESs) in chron…

BVS Expand Registry Evaluates Mid- to Long-Term Outcomes With Abbott’s Absorb Device

September 6, 2016 -- Mid- to long-term clinical outcomes of patients treated with the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular) i…

Health Canada Approves Abbott’s Absorb Bioresorbable Vascular Scaffold

July 14, 2016 -- Abbott Vascular announced that Health Canada has approved the company's Absorb bioresorbable heart stent for the treatment of patients with coronary arter…

FDA Approves Abbott Vascular’s Absorb Bioresorbable Vascular Scaffold

July 5, 2016 -- Abbott Vascular announced that the US Food and Drug Administration has approved the company's Absorb bioresorbable coronary stent.  Sold commercial…

Bioresorbables Plus Access & Closure

Ted E. Feldman, MD, MSCAI, FACC, FESC

May/June 2016— In this issue we highlight bioresorbable stent technologies and vascular access and closure. There are reviews covering recent trial results and the details of bioresorbab…

Current Status of Trial Outcomes for the Absorb Stent

Salvatore Cassese, MD, PhD

May/June 2016—How does Absorb compare to everolimus-eluting metallic stents?

Understanding the Technical Aspects of Bioresorbable Stent Implantation

Ashok Seth, FRCP, FACC, FSCAI, FESC, FCSI, DSc, DLitt; Vijay Kumar, MD, DNB; and Babu Ezhumalai, MD, DM, FNB, FISE

May/June 2016—The new Absorb polymer-based scaffold requires optimal implantation technique for best results.

How Will New Bioresorbable Polymer Drug-Eluting Stents Impact DAPT Duration?

Ian J. Sarembock, MBChB, MD, FACC; and Dean J. Kereiakes, MD, FACC

May/June 2016—Current bioresorbable polymer, everolimus-eluting stent technology appears well suited for abbreviated-duration dual-antiplatelet therapy.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.